GlassScriptPhysician profile
Robert M Paul
NPI 1972811412
$15,340.63
in general payments reported to CMS, 2019-2025
37 companies · $2,318 in 2025
The $2,318 reported for 2025 was more than what 94% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,508 · 2022: $4,333 · 2023: $3,812 · 2024: $3,371 · 2025: $2,318.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,312 · Travel and Lodging: $2,188.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,311.82 |
| Travel and Lodging | $2,188.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,827.44 | 2021-2025 | Wavewriter Alpha Prime 16, Intracept, Clinical Trial Product |
| Nevro Corp. | $1,829.52 | 2021-2024 | Senza |
| Saluda Medical Americas, INC. | $1,522.01 | 2023 | Evoke Scs |
| Biohaven Pharmaceutical Holding Company LTD. | $1,495.48 | 2022 | |
| Relievant Medsystems, INC. | $1,308.45 | 2022-2023 | Intracept |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $970.04 | 2022-2024 | Relistor |
| Forte Bio-Pharma LLC | $942.10 | 2023-2025 | Prolate, Nalocet, Tanlor |
| Collegium Pharmaceutical, INC. | $854.10 | 2021-2024 | Belbuca, Xtampza |
| Nalu Medical, INC. | $400.33 | 2021-2025 | Nalu Neurostimulation System |
| Abbott Laboratories | $381.75 | 2021-2025 | Prodigy, Proclaim, Thoratec Heartmate 3 Lvas Implant Kit |
| Axonics, INC. | $289.21 | 2024 | Axonics |
| Curonix LLC | $286.08 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Abbvie INC. | $244.13 | 2021-2023 | |
| Vertos Medical, INC. | $225.58 | 2022-2024 | Mild Device Kit |
| Painteq LLC | $211.35 | 2021-2024 | Painteq |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $196.77 | 2023-2025 | Ztlido |
| Merz Pharmaceuticals, LLC | $172.37 | 2021-2023 | Xeomin |
| Lilly USA, LLC | $138.79 | 2021-2023 | Emgality, Reyvow |
| Biohaven Pharmaceuticals, INC. | $129.27 | 2021 | |
| Allergan, INC. | $114.80 | 2021-2022 | |
| Azurity Pharmaceuticals, INC. | $95.22 | 2023-2024 | Horizant, Horizant |
| Pfizer INC. | $78.33 | 2021-2023 | |
| Hikma Pharmaceuticals USA | $74.10 | 2022 | |
| Arbor Pharmaceuticals, INC. | $73.99 | 2021-2022 | |
| Si-Bone, INC. | $73.00 | 2022-2024 | |
| Foundation Fusion Solutions, LLC | $64.60 | 2024 | |
| Amgen INC. | $59.04 | 2022-2024 | Evenity, Prolia |
| Kowa Pharmaceuticals America, INC. | $53.29 | 2022-2023 | Seglentis |
| Novo Nordisk INC | $47.59 | 2023 | Wegovy, Saxenda |
| Spinal Simplicity, LLC | $41.88 | 2023 | Ha Minuteman G3-R |
| Grt US Holding, INC. | $23.48 | 2021 | |
| Globus Medical, INC. | $23.27 | 2025 | Senza |
| Lundbeck LLC | $21.99 | 2021 | |
| Bioventus LLC | $21.22 | 2021 | |
| Alnylam Pharmaceuticals INC. | $17.44 | 2023 | Amvuttra |
| Teva Pharmaceuticals USA, INC. | $16.45 | 2021 | |
| Ibsa Pharma INC. | $16.17 | 2023 | Tirosint, Licart |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Paul listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.